Latest Regulatory Approval News

US1 Critical Minerals has agreed to transfer six Tanzanian uranium licences to Bradda Head Lithium for up to US$1.8 million, while retaining its Lilombe Project. The deal remains subject to regulatory approvals and other closing conditions.

Deep Yellow reported a A$13.3 million FY2026 profit and moved its Tumas uranium project closer to a targeted fourth-quarter investment decision. The company remains debt free, but acknowledges it will need external capital to fund construction.

PolyNovo delivered 16.1% revenue growth and a sharp improvement in operating cash flow in FY26, despite a lower statutory profit after a prior-year tax benefit and a fire-related write-off. The ASX-listed wound-care company now expects to lodge its U.S. PMA application for NovoSorb BTM before the end of 2026.

Brightstar Resources will pay A$350,000 for five Panther Metals exploration licences beside its Laverton processing plant, securing ground needed for haul roads, water infrastructure and future tailings capacity. A separate, non-binding deal could also bring Panther’s Burtville East ore through the plant under a 50:50 net proceeds arrangement.

Cygnus Metals’ shareholder vote on Central Asia Metals’ proposed acquisition remains scheduled for 18 September, but Kazakhstan regulatory approval may arrive too late for the current court timetable. The transaction has cleared several major hurdles, while the directors continue to recommend it.

Western Gold Resources is pursuing multiple processing alternatives for Gold Duke after Wiluna Mining deferred third-party tolling, while revising the project’s study around a larger resource. The company is also considering corporate opportunities, but no processing agreement, transaction or expanded mine plan has been secured.

Dimerix has secured Mexican composition of matter protection for its Phase 2-ready kidney drug DMX-652 until June 2041. The grant expands the asset’s patent estate ahead of planned clinical testing in acute kidney injury, although it brings no new clinical data or regulatory approval.

Alcoa has filed South32’s meeting materials ahead of a shareholder vote on the proposed sale of bauxite, alumina and aluminium interests. The transaction remains subject to shareholder approval, regulatory clearance, financing and other closing conditions.

Atlantic Lithium has reported a year of major progress at its Ewoyaa lithium project, including Ghanaian parliamentary approval of its mining lease and a proposed US$210 million takeover by Zhejiang Huayou Cobalt. But the audited accounts also flag material uncertainty over funding if the scheme does not proceed.

Venari Minerals says it knows of no undisclosed information behind a sharp rise in its share price and trading volume. The company points instead to ongoing Red Mountain drilling and a proposed exploration program still awaiting US regulatory approval.

Emyria has secured a limited in-person speaking position at a US FDA hearing examining how psychedelic medicines could be delivered safely and at scale. The appearance gives the ASX-listed company a regulatory platform, but does not represent FDA approval, funding or a commercial agreement.

Eagers Automotive has signed a non-binding agreement to acquire a 50% interest in Zagame Automotive Group, gaining exposure to 14 premium and luxury vehicle brands across Melbourne and Adelaide. The company expects the proposed joint venture to be immediately earnings accretive, although completion remains conditional and no transaction value has been disclosed.